Study investigated the incidence of certain adverse events following treatment with Ibrutinib in patients with CLL or mantle cell lymphoma.
Home / Resource Library / Characterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma